M2ES

DRUG3 trials

Sponsors

Tianjin Medical University Cancer Institute and Hospital, Protgen Ltd

Conditions

CancerNon Small Cell Lung CancerPancreatic Cancer

Phase 1

Study of M2ES in Patients With Advanced Pancreatic Cancer After Gemcitabine Treatment Failure

Protgen LtdPancreatic Cancer

Start: 2010-08-31End: 2011-12-31Target: 24Updated: 2010-10-28

Single-dose Escalation Trial of M2ES in Healthy Volunteer

CompletedNCT01223924

Protgen LtdCancer

Start: 2009-05-31End: 2009-09-30Updated: 2010-10-19

Unknown Phase

Study of M2ES With Paclitaxel/Carboplatin (TC Regimen) in Advanced Non Small Cell Lung Cancer (NSCLC)

CompletedNCT01099124

Tianjin Medical University Cancer Institute and HospitalNon Small Cell Lung Cancer

Start: 2009-12-31End: 2011-09-30Updated: 2013-01-29